Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > The Boss of nauseousguy - This Story Gets Better
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by cautiousguyon May 29, 2022 10:25pm
98 Views
Post# 34716035

RE:The Boss of nauseousguy - This Story Gets Better

RE:The Boss of nauseousguy - This Story Gets Better

Newcon/korncob -you are interchangable- can you explain why Roger -Braxia- would go to a company that you seem to feel is problematic?  Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022 [May 19 2022 Yahoo/Finance].    Is Roger the Boss, a dupe, a willing victim, a pawn?  Or, is your apparent support of this assertion -quoted below- about HC Wainwirght misguided like so many of your other claims?

Korcan wrote:

Posted on wallstreetoasis.com

"HC Wainwright is a fraudulent company . They pump and dump penny stocks. HC Wainwright accepts kickbacks for inside information. They have been subpoenaed for this exact issue. Look at the hourly wage paid for "investment bankers". Who pays an Investment banker an hourly wage, seriously? All of their analysts have unverifiable credentials. Individuals they post with "legitimate" creds are listed on the site that have the same name of people with said credential that work for other firms . Very surprised this company hasn't been forced to shut it's doors. Anyone one here interviewing with this company must have their MBA from Devry. Goodluck."



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities